Wells initiates Pfizer at overweight, says Covid treatments are here to stay

A woman holds a small bottle labeled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in front of displayed Pfizer logo in this illustration taken, October 30, 2020.
Dado Ruvic | Reuters

Pfizer is poised to outperform as its Covid treatments stick around and generate major revenue for the company, according to Wells Fargo.